Radiation Exposure, Inflammation and Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".
Deadline for manuscript submissions: 25 August 2024 | Viewed by 138
Special Issue Editor
Special Issue Information
Dear Colleagues,
Radiation therapy stands as a crucial pillar in the realm of cancer treatment, employing targeted approaches to obliterate cancerous cells. The efficacy of this treatment is undeniable; nevertheless, it comes with challenges. Exposure to ionizing radiation, encompassing gamma and X-rays, and the utilization of sophisticated particle beams in therapy, while instrumental in battling cancer, can concurrently result in damage to normal tissues and elevate the risk of developing subsequent cancers. As the scope extends beyond the confines of terrestrial cancer treatment, our attention pivots toward the cosmos, unraveling the potential implications of radiation exposure on the health of astronauts during future space missions. Prolonged exposure to cosmic radiation presents a multifaceted challenge to the health and well-being of astronauts, necessitating a comprehensive exploration of preventative strategies and effective mitigation techniques to safeguard their physical integrity.
This Special Issue aims to unravel the complexities surrounding the effectiveness and potential adverse effects of various radiation types in biological systems. By examining the mechanisms and consequences of radiation exposure, the issue seeks to enhance our collective knowledge, inform strategies that advance cancer treatment and address the unique challenges posed by cosmic radiation in the extraterrestrial realm.
You are invited to contribute a research or review article to this Special Issue. As an expert, your insights will undoubtedly enrich the discourse, providing a more comprehensive understanding of how radiation exposure affects cancer growth, and your contribution will have a crucial role in advancing our knowledge and developing innovative solutions.
Dr. Santosh Kumar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiation
- DNA damage response
- inflammation
- oxidative stress
- senescence and cancer
